Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Xiao ChangLei DengWenjie NiChen LiWeiming HanLin-Rui GaoShijia WangZongmei ZhouDongfu ChenQinfu FengJun LiangNan BiJima LvShugeng GaoYousheng MaoQi XueZefen XiaoPublished in: BMC cancer (2020)
Prospectively Registered. ClinicalTrials.gov NCT03731442 , Registered November 6, 2018.
Keyphrases
- minimally invasive
- clinical trial
- end stage renal disease
- coronary artery bypass
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- peritoneal dialysis
- prognostic factors
- palliative care
- double blind
- surgical site infection
- squamous cell carcinoma
- study protocol
- rectal cancer
- patient reported outcomes
- open label
- phase ii
- advanced cancer